{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T00:15:38Z","timestamp":1785024938645,"version":"3.55.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s10072-025-08689-4","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T08:18:51Z","timestamp":1767428331000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Programmed cell death pathways in Huntington\u2019s disease: spotlight on ferroptosis and pyroptosis"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6061-2012","authenticated-orcid":false,"given":"Veerta","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1774-3105","authenticated-orcid":false,"given":"Reet","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3656-669X","authenticated-orcid":false,"given":"Prateek","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2979-1590","authenticated-orcid":false,"given":"Thakur Gurjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"issue":"2","key":"8689_CR1","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s10072-024-07802-3","volume":"46","author":"V Sharma","year":"2025","unstructured":"Sharma V, Sharma P, Singh TG (2025) Mechanistic insights on the role of Nrf-2 signalling in huntington\u2019s disease. Neurol Sci 46(2):593\u2013604","journal-title":"Neurol Sci"},{"issue":"3","key":"8689_CR2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2174\/1871527322666230327092855","volume":"23","author":"L Kapil","year":"2024","unstructured":"Kapil L, Kumar V, Kaur S, Sharma D, Singh C, Singh A (2024) Role of autophagy and mitophagy in neurodegenerative disorders. CNS & Neurological Disorders 23(3):367\u2013383","journal-title":"CNS & Neurological Disorders"},{"key":"8689_CR3","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.00082","volume":"14","author":"S Blumenstock","year":"2020","unstructured":"Blumenstock S, Dudanova I (2020) Cortical and striatal circuits in Huntington\u2019s disease. Front Neurosci 14:82","journal-title":"Front Neurosci"},{"issue":"6","key":"8689_CR4","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s12272-024-01499-w","volume":"47","author":"A Shafie","year":"2024","unstructured":"Shafie A, Ashour AA, Anwar S, Anjum F, Hassan MI (2024) Exploring molecular mechanisms, therapeutic strategies, and clinical manifestations of huntington\u2019s disease. Arch Pharm Res 47(6):571\u2013595","journal-title":"Arch Pharm Res"},{"issue":"7","key":"8689_CR5","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1038\/s41418-021-00814-y","volume":"28","author":"D Moujalled","year":"2021","unstructured":"Moujalled D, Strasser A, Liddell JR (2021) Molecular mechanisms of cell death in neurological diseases. Cell Death Differ 28(7):2029\u20132044","journal-title":"Cell Death Differ"},{"issue":"18","key":"8689_CR6","volume":"25","author":"D Guo","year":"2024","unstructured":"Guo D, Liu Z, Zhou J, Ke C, Li D (2024) Significance of programmed cell death pathways in neurodegenerative diseases. Int J Mol Sci 25(18):9947","journal-title":"Int J Mol Sci"},{"issue":"1","key":"8689_CR7","volume":"19","author":"J Cui","year":"2021","unstructured":"Cui J, Zhao S, Li Y, Zhang D, Wang B, Xie J, Wang J (2021) Regulated cell death: discovery, features and implications for neurodegenerative diseases. Cell Communication and Signaling 19(1):120","journal-title":"Cell Communication and Signaling"},{"issue":"2","key":"8689_CR8","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s12017-018-8518-6","volume":"21","author":"Y Mi","year":"2019","unstructured":"Mi Y, Gao X, Xu H, Cui Y, Zhang Y, Gou X (2019) The emerging roles of ferroptosis in huntington\u2019s disease. Neuromol Med 21(2):110\u2013119","journal-title":"Neuromol Med"},{"issue":"3","key":"8689_CR9","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s12035-023-03646-8","volume":"61","author":"NJ Dar","year":"2024","unstructured":"Dar NJ, John U, Bano N, Khan S, Bhat SA (2024) Oxytosis\/ferroptosis in neurodegeneration: the underlying role of master regulator glutathione peroxidase 4 (GPX4). Mol Neurobiol 61(3):1507\u20131526","journal-title":"Mol Neurobiol"},{"issue":"15","key":"8689_CR10","doi-asserted-by":"crossref","first-page":"8363","DOI":"10.3390\/ijms23158363","volume":"23","author":"E Paldino","year":"2022","unstructured":"Paldino E, Fusco FR (2022) Emerging role of NLRP3 inflammasome\/pyroptosis in huntington\u2019s disease. Int J Mol Sci 23(15):8363","journal-title":"Int J Mol Sci"},{"issue":"4","key":"8689_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11011-025-01587-w","volume":"40","author":"V Sharma","year":"2025","unstructured":"Sharma V, Sharma P, Singh TG (2025) Ferroptosis and alzheimer\u2019s: unveiling new avenues for the treatment and prevention. Metab Brain Dis 40(4):1\u201313","journal-title":"Metab Brain Dis"},{"key":"8689_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.70028","author":"H Yu","year":"2025","unstructured":"Yu H, Fu L, Zhang C, Wang S, Song J, Zhu Y, Wang F (2025) Targeting ferroptosis with natural products to treat diabetes and its complications: opportunities and challenges. Phytother Res. https:\/\/doi.org\/10.1002\/ptr.70028","journal-title":"Phytother Res"},{"key":"8689_CR13","unstructured":"Shirley K (2021) Off-Target Activities of Lipoxygenase Inhibitors Confound the Role of Enzyme-Catalyzed (Phospho) Lipid Peroxidation in Ferroptosis (Doctoral dissertation, Universit\u00e9 d\u2019Ottawa\/University of Ottawa)"},{"issue":"21","key":"8689_CR14","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.3390\/molecules25215144","volume":"25","author":"SM Clemente","year":"2020","unstructured":"Clemente SM, Mart\u00ednez-Costa OH, Monsalve M, Samhan-Arias AK (2020) Targeting lipid peroxidation for cancer treatment. Molecules 25(21):5144","journal-title":"Molecules"},{"issue":"3","key":"8689_CR15","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.tips.2021.12.001","volume":"43","author":"L Heinrich","year":"2022","unstructured":"Heinrich L, Booijink R, Khurana A, Weiskirchen R, Bansal R (2022) Lipoxygenases in chronic liver diseases: current insights and future perspectives. Trends Pharmacol Sci 43(3):188\u2013205","journal-title":"Trends Pharmacol Sci"},{"key":"8689_CR16","doi-asserted-by":"crossref","unstructured":"Das B, Ray P, Raut S (2021) Impaired mitochondrial energy metabolism: etiologies and implications in neurodegenerative disease. Clinical bioenergetics. Academic, pp 93\u2013118","DOI":"10.1016\/B978-0-12-819621-2.00004-8"},{"issue":"2","key":"8689_CR17","doi-asserted-by":"crossref","first-page":"714","DOI":"10.14336\/AD.2023.0717","volume":"15","author":"F Feng","year":"2024","unstructured":"Feng F, He S, Li X, He J, Luo L (2024) Mitochondria-mediated ferroptosis in diseases therapy: from molecular mechanisms to implications. Aging Dis 15(2):714","journal-title":"Aging Dis"},{"issue":"5","key":"8689_CR18","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3390\/antiox11050801","volume":"11","author":"D Matuz-Mares","year":"2022","unstructured":"Matuz-Mares D, Gonz\u00e1lez-Andrade M, Araiza-Villanueva MG, Vilchis-Landeros MM, V\u00e1zquez-Meza H (2022) Mitochondrial calcium: effects of its imbalance in disease. Antioxidants 11(5):801","journal-title":"Antioxidants"},{"key":"8689_CR19","volume":"10","author":"C Fu","year":"2023","unstructured":"Fu C, Cao N, Zeng S, Zhu W, Fu X, Liu W, Fan S (2023) Role of mitochondria in the regulation of ferroptosis and disease. Front Med 10:1301822","journal-title":"Front Med"},{"key":"8689_CR20","unstructured":"Tu H, Tang LJ, Luo XJ, Ai KL, Peng J (2021) Insights into the novel function of system Xc-in regulated cell death. Eur Rev Med Pharmacol Sci, 25(3)"},{"issue":"18","key":"8689_CR21","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201800311","volume":"19","author":"GC Forcina","year":"2019","unstructured":"Forcina GC, Dixon SJ (2019) GPX4 at the crossroads of lipid homeostasis and ferroptosis. Proteomics 19(18):1800311","journal-title":"Proteomics"},{"issue":"5","key":"8689_CR22","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3390\/antiox14050527","volume":"14","author":"N Abdukarimov","year":"2025","unstructured":"Abdukarimov N, Kokabi K, Kunz J (2025) Ferroptosis and iron homeostasis: molecular mechanisms and neurodegenerative disease implications. Antioxidants 14(5):527","journal-title":"Antioxidants"},{"issue":"6","key":"8689_CR23","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","volume":"25","author":"SJ Dixon","year":"2024","unstructured":"Dixon SJ, Olzmann JA (2024) The cell biology of ferroptosis. Nat Rev Mol Cell Biol 25(6):424\u2013442","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"8689_CR24","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3174\/ajnr.A4617","volume":"37","author":"JM Van Bergen","year":"2016","unstructured":"Van Bergen JM, Hua J, Unschuld PG, Lim IAL, Jones CK, Margolis RL, van Bergen JMG, Ross CA, van Zijl PCM, Li X (2016) Quantitative susceptibility mapping suggests altered brain iron in premanifest Huntington disease. AJNR Am J Neuroradiol 37(5):789\u2013796","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"8689_CR25","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.molcel.2018.10.042","volume":"73","author":"M Gao","year":"2019","unstructured":"Gao M, Yi J, Zhu J, Minikes AM, Monian P, Thompson CB, Jiang X (2019) Role of mitochondria in ferroptosis. Mol Cell 73(2):354\u2013363","journal-title":"Mol Cell"},{"issue":"15","key":"8689_CR26","doi-asserted-by":"crossref","first-page":"5826","DOI":"10.7150\/thno.100080","volume":"14","author":"S Li","year":"2024","unstructured":"Li S, Zhang G, Hu J, Tian Y, Fu X (2024) Ferroptosis at the nexus of metabolism and metabolic diseases. Theranostics 14(15):5826","journal-title":"Theranostics"},{"key":"8689_CR27","doi-asserted-by":"crossref","unstructured":"Jamal MH, Dhupar M, Aran KR (2025) Exploring the Role of Ferroptosis Pathways in Huntington\u2019s Disease: Insight of Pathophysiology to Emerging Treatment. Brain Disorders, 100207","DOI":"10.1016\/j.dscb.2025.100207"},{"issue":"1","key":"8689_CR28","doi-asserted-by":"crossref","first-page":"15515","DOI":"10.1038\/s41598-023-42760-4","volume":"13","author":"Y Chen","year":"2023","unstructured":"Chen Y, Guo X, Zeng Y, Mo X, Hong S, He H, Liu Q (2023) Oxidative stress induces mitochondrial iron overload and ferroptotic cell death. Sci Rep 13(1):15515","journal-title":"Sci Rep"},{"issue":"1","key":"8689_CR29","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/s41598-017-18935-1","volume":"8","author":"C Wu","year":"2018","unstructured":"Wu C, Zhao W, Yu J, Li S, Lin L, Chen X (2018) Induction of ferroptosis and mitochondrial dysfunction by oxidative stress in PC12 cells. Sci Rep 8(1):574","journal-title":"Sci Rep"},{"issue":"5","key":"8689_CR30","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s10534-018-0126-2","volume":"31","author":"A Carocci","year":"2018","unstructured":"Carocci A, Catalano A, Sinicropi MS, Genchi G (2018) Oxidative stress and neurodegeneration: the involvement of iron. Biometals 31(5):715\u2013735","journal-title":"Biometals"},{"issue":"1","key":"8689_CR31","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41419-021-04490-1","volume":"13","author":"S Zhang","year":"2022","unstructured":"Zhang S, Xin W, Anderson GJ, Li R, Gao L, Chen S, Liu S (2022) Double-edge sword roles of iron in driving energy production versus instigating ferroptosis. Cell Death Dis 13(1):40","journal-title":"Cell Death Dis"},{"key":"8689_CR32","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mito.2023.03.001","volume":"70","author":"Y Dai","year":"2023","unstructured":"Dai Y, Wang H, Lian A, Li J, Zhao G, Hu S, Li B (2023) A comprehensive perspective of Huntington\u2019s disease and mitochondrial dysfunction. Mitochondrion 70:8\u201319","journal-title":"Mitochondrion"},{"key":"8689_CR33","doi-asserted-by":"crossref","DOI":"10.1177\/09636897221105499","volume":"31","author":"N Hastings","year":"2022","unstructured":"Hastings N, Kuan WL, Osborne A, Kotter MR (2022) Therapeutic potential of astrocyte transplantation. Cell Transplant 31:09636897221105499","journal-title":"Cell Transplant"},{"key":"8689_CR34","doi-asserted-by":"crossref","unstructured":"Dabi YT, Ajagbe AO, Degechisa ST (2023) Toll-like receptors in pathogenesis of neurodegenerative diseases and their therapeutic potential. Immun Inflamm Dis, 11(4), e839","DOI":"10.1002\/iid3.839"},{"key":"8689_CR35","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2019.00258","volume":"12","author":"TH Palpagama","year":"2019","unstructured":"Palpagama TH, Waldvogel HJ, Faull RL, Kwakowsky A (2019) The role of microglia and astrocytes in Huntington\u2019s disease. Front Mol Neurosci 12:258","journal-title":"Front Mol Neurosci"},{"issue":"Suppl 4","key":"8689_CR36","doi-asserted-by":"crossref","first-page":"S683","DOI":"10.33549\/physiolres.934712","volume":"70","author":"H Rauchova","year":"2021","unstructured":"Rauchova H (2021) Coenzyme Q10 effects in neurological diseases. Physiol Res 70(Suppl 4):S683","journal-title":"Physiol Res"},{"key":"8689_CR37","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3389\/fphar.2020.00239","volume":"11","author":"C Han","year":"2020","unstructured":"Han C, Liu Y, Dai R, Ismail N, Su W, Li B (2020) Ferroptosis and its potential role in human diseases. Front Pharmacol 11:239","journal-title":"Front Pharmacol"},{"issue":"23","key":"8689_CR38","doi-asserted-by":"crossref","first-page":"E4676","DOI":"10.1073\/pnas.1614943114","volume":"114","author":"L Quinti","year":"2017","unstructured":"Quinti L, Dayalan Naidu S, Tr\u00e4ger U, Chen X, Kegel-Gleason K, Ll\u00e8res D, Connolly Col\u00fam, Chopra Vanita, Low Cho, Moniot S\u00e9bastien, Sapp Ellen, Tousley Adelaide R., Vodicka Petr, Van Kanegan Michael J., Kaltenbach Linda S., Crawford Lisa A., Fuszard Matthew, Higgins Maureen, Miller James R. C., Farmer Ruth E., Potluri Vijay, Samajdar Susanta, Meisel Lisa, Zhang Ningzhe, Snyder Andrew, Stein Ross, Hersch Steven M., Ellerby Lisa M., Weerapana Eranthie, Schwarzschild Michael A., Steegborn Clemens, Leavitt Blair R., Degterev Alexei, Tabrizi Sarah J., Lo Donald C., DiFiglia Marian, Thompson Leslie M., Dinkova-Kostova Albena T., Kazantsev AG (2017) KEAP1-modifying small molecule reveals muted NRF2 signaling responses in neural stem cells from Huntington\u2019s disease patients. Proc Natl Acad Sci USA 114(23):E4676\u2013E4685","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"8689_CR39","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1021\/ja411006a","volume":"136","author":"R Skouta","year":"2014","unstructured":"Skouta R, Dixon SJ, Wang J, Dunn DE, Orman M, Shimada K, Stockwell BR (2014) Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models. J Am Chem Soc 136(12):4551\u20134556","journal-title":"J Am Chem Soc"},{"key":"8689_CR40","doi-asserted-by":"crossref","unstructured":"Chen J, Marks E, Lai B, Zhang Z, Duce JA, Lam LQ, Fox JH (2013) Iron accumulates in huntington\u2019s disease neurons: protection by deferoxamine. PLoS ONE, 8(10), e77023","DOI":"10.1371\/journal.pone.0077023"},{"issue":"1","key":"8689_CR41","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s12035-021-02571-y","volume":"59","author":"H Ge","year":"2022","unstructured":"Ge H, Xue X, Xian J, Yuan L, Wang L, Zou Y, Hu S (2022) Ferrostatin-1 alleviates white matter injury via decreasing ferroptosis following spinal cord injury. Mol Neurobiol 59(1):161\u2013176","journal-title":"Mol Neurobiol"},{"issue":"6","key":"8689_CR42","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/03630269.2014.965781","volume":"38","author":"KH Kuo","year":"2014","unstructured":"Kuo KH, Mrkobrada M (2014) A systematic review and meta-analysis of deferiprone monotherapy and in combination with deferoxamine for reduction of iron overload in chronically transfused patients with \u03b2-thalassemia. Hemoglobin 38(6):409\u2013421","journal-title":"Hemoglobin"},{"issue":"1","key":"8689_CR43","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12883-015-0331-3","volume":"15","author":"G Grolez","year":"2015","unstructured":"Grolez G, Moreau C, Sablonni\u00e8re B, Gar\u00e7on G, Devedjian JC, Meguig S, Devos D (2015) Ceruloplasmin activity and iron chelation treatment of patients with parkinson\u2019s disease. BMC Neurol 15(1):74","journal-title":"BMC Neurol"},{"key":"8689_CR44","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neuroscience.2016.07.003","volume":"332","author":"J Sripetchwandee","year":"2016","unstructured":"Sripetchwandee J, Wongjaikam S, Krintratun W, Chattipakorn N, Chattipakorn SC (2016) A combination of an iron chelator with an antioxidant effectively diminishes the dendritic loss, tau-hyperphosphorylation, amyloids-\u03b2 accumulation and brain mitochondrial dynamic disruption in rats with chronic iron-overload. Neuroscience 332:191\u2013202","journal-title":"Neuroscience"},{"key":"8689_CR45","doi-asserted-by":"crossref","unstructured":"Wongjaikam S, Kumfu S, Khamseekaew J, Sripetchwandee J, Srichairatanakool S, Fucharoen S, Chattipakorn N (2016) Combined iron chelator and antioxidant exerted greater efficacy on cardioprotection than monotherapy in iron-overloaded rats. PLoS ONE, 11(7), e0159414","DOI":"10.1371\/journal.pone.0159414"},{"issue":"1","key":"8689_CR46","volume":"6","author":"P Yu","year":"2021","unstructured":"Yu P, Zhang X, Liu N, Tang L, Peng C, Chen X (2021) Pyroptosis: mechanisms and diseases. Signal Transduct Target Ther 6(1):128","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"8689_CR47","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s12026-022-09286-9","volume":"70","author":"N Challagundla","year":"2022","unstructured":"Challagundla N, Saha B, Agrawal-Rajput R (2022) Insights into inflammasome regulation: cellular, molecular, and pathogenic control of inflammasome activation. Immunol Res 70(5):578\u2013606","journal-title":"Immunol Res"},{"key":"8689_CR48","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.abb.2019.02.008","volume":"670","author":"JM Platnich","year":"2019","unstructured":"Platnich JM, Muruve DA (2019) NOD-like receptors and inflammasomes: a review of their canonical and non-canonical signaling pathways. Arch Biochem Biophys 670:4\u201314","journal-title":"Arch Biochem Biophys"},{"key":"8689_CR49","doi-asserted-by":"crossref","first-page":"1178662","DOI":"10.3389\/fimmu.2023.1178662","volume":"14","author":"Z Dai","year":"2023","unstructured":"Dai Z, Liu WC, Chen XY, Wang X, Li JL, Zhang X (2023) Gasdermin D-mediated pyroptosis: mechanisms, diseases, and inhibitors. Front Immunol 14:1178662","journal-title":"Front Immunol"},{"issue":"1","key":"8689_CR50","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41420-020-00293-z","volume":"6","author":"E Paldino","year":"2020","unstructured":"Paldino E, D\u2019Angelo V, Sancesario G, Fusco FR (2020) Pyroptotic cell death in the R6\/2 mouse model of huntington\u2019s disease: new insight on the inflammasome. Cell Death Discov 6(1):69","journal-title":"Cell Death Discov"},{"issue":"5","key":"8689_CR51","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.str.2018.03.002","volume":"26","author":"Z Liu","year":"2018","unstructured":"Liu Z, Wang C, Rathkey JK, Yang J, Dubyak GR, Abbott DW, Xiao TS (2018) Structures of the gasdermin D C-terminal domains reveal mechanisms of autoinhibition. Structure 26(5):778\u2013784","journal-title":"Structure"},{"key":"8689_CR52","volume":"76","author":"L Wang","year":"2020","unstructured":"Wang L, Hauenstein AV (2020) The NLRP3 inflammasome: mechanism of action, role in disease and therapies. Mol Aspects Med 76:100889","journal-title":"Mol Aspects Med"},{"key":"8689_CR53","volume":"14","author":"YR Liu","year":"2023","unstructured":"Liu YR, Wang JQ, Li J (2023) Role of NLRP3 in the pathogenesis and treatment of gout arthritis. Front Immunol 14:1137822","journal-title":"Front Immunol"},{"issue":"10","key":"8689_CR54","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1002\/eji.201545523","volume":"45","author":"JL Schmid-Burgk","year":"2015","unstructured":"Schmid-Burgk JL, Gaidt MM, Schmidt T, Ebert TS, Bartok E, Hornung V (2015) Caspase\u20104 mediates non\u2010canonical activation of the NLRP3 inflammasome in human myeloid cells. Eur J Immunol 45(10):2911\u20132917","journal-title":"Eur J Immunol"},{"key":"8689_CR55","unstructured":"Feng S (2022) Guanylate-binding proteins as mediators of inflammasome activation in response to bacterial infection (Doctoral dissertation, The Australian National University (Australia))"},{"issue":"10","key":"8689_CR56","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.3390\/cells9102286","volume":"9","author":"E Paldino","year":"2020","unstructured":"Paldino E, D\u2019Angelo V, Laurenti D, Angeloni C, Sancesario G, Fusco FR (2020) Modulation of inflammasome and pyroptosis by olaparib, a PARP-1 inhibitor, in the R6\/2 mouse model of huntington\u2019s disease. Cells 9(10):2286","journal-title":"Cells"},{"issue":"1","key":"8689_CR57","volume":"19","author":"KP Chen","year":"2022","unstructured":"Chen KP, Hua KF, Tsai FT, Lin TY, Cheng CY, Yang DI, Hsu Hsien-Ta, Ju TC (2022) A selective inhibitor of the NLRP3 inflammasome as a potential therapeutic approach for neuroprotection in a transgenic mouse model of Huntington\u2019s disease. J Neuroinflammation 19(1):56","journal-title":"J Neuroinflammation"},{"issue":"1","key":"8689_CR58","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1038\/s41467-019-11441-0","volume":"10","author":"JJ Siew","year":"2019","unstructured":"Siew JJ, Chen HM, Chen HY, Chen HL, Chen CM, Soong BW, Chern Y (2019) Galectin-3 is required for the microglia-mediated brain inflammation in a model of Huntington\u2019s disease. Nat Commun 10(1):3473","journal-title":"Nat Commun"},{"issue":"1","key":"8689_CR59","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s10020-024-00917-5","volume":"30","author":"ME Noureldeen","year":"2024","unstructured":"Noureldeen ME, Shahin NN, Amin HAA, El-Sawalhi MM, Ghaiad HR (2024) Parthenolide ameliorates 3-nitropropionic acid-induced Huntington\u2019s disease-like aberrations via modulating NLRP3 inflammasome, reducing microglial activation and inducing astrocyte shifting. Mol Med 30(1):158","journal-title":"Mol Med"},{"issue":"1","key":"8689_CR60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11481-024-10161-7","volume":"20","author":"YJ Chang","year":"2024","unstructured":"Chang YJ, Chen CH, Chen YC, Wu MT, Lin TY, Hua KF, Ju TC (2024) Protective effects of Antcin H isolated from antrodia cinnamomea against neuroinflammation in Huntington\u2019s disease via NLRP3 inflammasome inhibition. J Neuroimmune Pharmacol 20(1):1","journal-title":"J Neuroimmune Pharmacol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08689-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-025-08689-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08689-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T16:03:39Z","timestamp":1773072219000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-025-08689-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["8689"],"URL":"https:\/\/doi.org\/10.1007\/s10072-025-08689-4","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"6 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics approval and consent to participate"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"N\/A.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"There are no conflicts of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"83"}}